Moderna
MRNA
#412
Rank
$46.79 B
Marketcap
$122.11
Share price
1.42%
Change (1 day)
1.21%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: $46.79 Billion

As of July 2024 Moderna has a market cap of $46.79 Billion. This makes Moderna the world's 412th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Market cap Change
2024$46.79 B23.42%
2023$37.91 B-45.05%
2022$69.00 B-32.99%
2021$102.97 B149.1%
2020$41.33 B528.01%
2019$6.58 B31.11%
2018$5.02 B

End of Day market cap according to different sources

On Jul 25th, 2024 the market cap of Moderna was reported to be:

$46.14 Billion
by Yahoo Finance info icon info icon
$46.14 Billion
by CompaniesMarketCap info icon info icon
$46.14 Billion
by Nasdaq info icon info icon
$46.15 Billion
by Iex Cloud info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$0.11 B-99.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$317.25 B 577.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.83 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.70 B-36.52%๐Ÿ‡บ๐Ÿ‡ธ USA
$223.35 B 377.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$3.50 B-92.52%๐Ÿ‡บ๐Ÿ‡ธ USA
$386.60 B 726.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.97 B-93.64%๐Ÿ‡บ๐Ÿ‡ธ USA